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Ohe Centers for Disease Con-
trol and Prevention published
Guidelines for Preventing the
Transmission of Tuberculosis in
Health-Care Settings, with
Special Focus on HIV-Related
Issues' in December 1990.
Partially in response to recent
reports ofTB outbreaks and
transmission ofMycobacterium
tuberculosis in institutional set-
tings,27 the Federal TB Task
Force called for the update and
revision of the CDC guidelines.
On Oct. 28, 1994, the CDC pub-
lished Guidelines for
Preventing the Transmission of
Mycobacterium tuberculosis in
Health Care Facilities, 1994.8
At an October 1992 public
meeting about the 1990 TB in-
fection control guidelines, the
CDC received suggestions that
infection control policies should
be based, in part, on the level of
risk in each local facility. As a
consequence, the revised guide-
lines direct personnel in all
health care facilities to conduct
a TB risk assessment. This risk
assessment will allow health
care personnel to implement TB
infection control programs ap-
propriate to their facility's level
of risk ofM. tuberculosis trans-
mission. It also will provide
greater flexibility in adapting
the recommended controls to a
wide variety of health care facil-
ities, such as dental settings, in
Between 1989 and 1992, reports
of outbreaks and transmissions
of tuberculosis in institutional
settings prompted the Centers
for Disease Control and Preven-
tion to review the guidelines for
TB infection control it had pub-
lished in 1990. The CDC pub-
lished an updated version of the
guidelines in October 1994. This
article gives dentists an
overview of the guidelines' rec-
ommendations that are applica-
ble to most outpatient dental
settings.
which few or no patients with
TB are examined or treated.
The guidelines emphasize
- basing infection control poli-
cies on a hierarchy of control
measures, including adminis-
trative controls, engineering
controls and personal respira-
tory protection (Table 1);
- developing, implementing
and maintaining a written TB
infection control plan based on
a risk assessment;
- providing TB training, educa-
tion, counseling and screening
to health care workers (HCWs);
- evaluating TB infection
control programs.
This article should assist
dental workers (DWs) in con-
ducting a risk assessment and
in identifying TB infection con-
trol interventions appropriate to
the level of risk for M. tuberculo-
sis transmission in the dental
facility.
Although the CDC guidelines
are directed primarily at in-pa-
tient health care facilities, spe-
cific considerations for ambula-
tory care settings-such as den-
tal offices-are discussed in a
separate section [Section
II.M.2.eI (see sidebar, "CDC
Guidelines for Dental Care
Settings," page 600) with appro-
priate references to other parts
of the guidelines. In this article,
references to specific sections of
the CDC guidelines are indicat-
ed in brackets. The term
"HCWs" refers to all persons
working in health care settings
who could be exposed to TB.
The terms dental facility, dental
setting and dental office are
used interchangeably and refer
to any location, whether a pri-
vate practice or part of a larger





TB is a clinical illness caused by
the bacterium M. tuberculosis.
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TABLE I
Effective prevention and control
ofM. tuberculosis is based on a
clear understanding of how TB
is transmitted, how infection
becomes established and how
infection progresses to clinical
disease.
M. tuberculosis is spread
through airborne particles,
known as droplet nuclei, that
can be generated when persons
with pulmonary or laryngeal TB
sneeze, cough, speak or sing.
The particles are an estimated
1 to 5 microns in size, and nor-
mal air currents can keep them
airborne for prolonged periods
and spread them throughout a
room or building.9 If a person
inhales droplet nuclei contain-
ing TB bacilli, infection may
begin if the bacilli reach the
alveoli. Within two to 10 weeks,
the body's immunologic
response to TB bacilli usually
prevents further multiplication
and spread. This condition is
referred to as latent TB infec-
tion.
Persons with latent TB infec-
tion usually have a positive skin
test reaction to tuberculin puri-
fied protein derivative (PPD), do
not have active TB and cannot
infect others. In about 90 per-
cent ofAmericans infected with
TB, the infection remains latent
for life, with no progression to
active TB. In the United States,
active TB disease will develop in
the first year or two after in-
fection with M. tuberculosis in
about 5 percent of people who
have been recently infected. In
another 5 percent, disease will
develop later in life. The risk of
developing active TB varies with
age and immunologic status.10
In general, people not receiv-
ing treatment who have or who
are suspected of having pul-
monary or laryngeal TB should
be considered infectious if they
are coughing, are undergoing
cough-inducing or aerosol-gen-
erating procedures or have spu-
tum smears that are positive for
acid-fast bacilli [Suppl. 1]. Per-
sons with extrapulmonary TB
are not considered infectious
unless they have concomitant
pulmonary disease, nonpul-
monary disease located in the
respiratory tract or oral cavity
or extrapulmonary disease that
includes an open abscess or
lesion. Coinfection of human
immunodeficiency virus does
not appear to affect the infec-
tiousness of patients with TB.
Hierarchy of control
measures. A facility's TB infec-
tion control program should be
based on a hierarchy of control
measures (Table 1) and should
be appropriate for the facility's
level of risk ofM. tuberculosis
transmission (Table 2). The first
level in the hierarchy is the use
of administrative controls,
which are intended primarily to
reduce the risk of exposing
uninfected people to people who
have infectious TB. These meas-
ures include developing and
implementing policies and pro-
tocols for early identification
and isolation of patients
suspected of having active TB
or, in facilities that do not have
TB isolation capabilities, for
referral to a collaborating facil-
ity that does have such capabili-
ties. Other administrative
measures include ensuring the
use of effective work practices,
performing PPD skin testing on
HCWs and educating HCWs
about TB.
The second level of the hier-
archy includes engineering con-
trols to prevent the spread and
reduce the concentration of
infectious droplet nuclei. These
controls may include the use of
local exhaust devices (such as
booths or hoods), the dilution
and removal of contaminated
air via general ventilation, con-
trolling the direction of airflow
and cleaning air by filtration
or-as an adjunct to ventila-
tion-by ultraviolet germicidal




Does not treat pPatnts Swith Minimnal 0ri]lsk
active tuberc6ulosis and no TB
cases have been reported in the
community in the preceding
12 months*
Doesnottret ptiets ith Very lwrs
communi4t0r ;0,ty; t00 .tsce n pt ients0?000
for actlive TBand reer
suspected TB3 cases to
collabor-ating facility for
evaluzation and management
Provides treatment to fewer than Low riskC
s-ix patients w~ith active T per
year and thereis no evidence Of
M4ycobacterium tuberculosis
transmission in the facilityfo
Provdestretmet to'i or Inemdaersk
Al. tuberlonsans per year and
there is no evidnce f TB
transmission in the famility
Evidence 0 trasiio of High risk
M. tuberculosis in the facility
* Incidence ofTB in thecommunity should be available firom the local public health depart-
ment.
t As evidenced by PPD skin test conversions among dental workers or patients.
irradiation (UVGI).
The third level of the hierar-
chy is the use of personal respi-
ratory protection devices in set-
tings such as TB isolation
rooms, where administrative
and engineering controls may







In all dental settings, an initial
or baseline risk assessment
should be conducted by a desig-
nated person who understands
the basic principles of infection
control and can adapt TB infec-
tion control recommendations
according to the facility's level
of risk for M. tuberculosis trans-
mission. In institutional dental
settings, this person may be the
hospital epidemiologist, an
infection control practitioner or
an occupational health special-
ist. In non-institutional dental
settings, such as private dental
offices, the risk assessment usu-
ally is conducted by the dentist
or another staff member who
has been assigned responsibility
for the office's infection control
program. Sources for training
specific to TB infection control
risk assessment may include
the local public health depart-
ment, state or local dental soci-
ety, academic institutions, a
local infection control organiza-
tion or an infection control prac-
titioner in a local hospital. The
guidelines recommend that the
risk assessment should be con-
ducted for each area of the facil-
ity. Since most dental settings
constitute an entire "area," a
single risk assessment should
be sufficient.
Risk categories. Each den-
tal facility should be classified
into one of five defined cate-
gories of risk for M. tuberculosis
transmission: minimal, very
low, low, intermediate or high
(Table 2). This classification
should be based on three fac-
tors. The first factor is the inci-
dence of active TB in the com-
munity or county served by the
facility. This information should
be available from the local or
county public health depart-
ment. The second factor is the
number of patients with active
TB who received dental treat-
ment in the facility during the
preceding 12 months (this does
not include patients who were
promptly screened and re-
ferred). The third factor is pos-
sible transmission ofM. tuber-
culosis in the facility as evi-
denced by PPD skin test conver-
sions among DWs or evidence of
transmission between patients
in the dental setting.
Minimal risk. Most dental
settings probably will fall into
the minimal- or very-low-risk
categories. A dental setting at
minimal risk is one that does
not provide treatment to pa-
tients with active TB and is lo-
cated in a community in which
no TB cases have been reported
during the previous 12 months.




Educating and training dental workers
regardling TB
Counseling dental workers regarding TB R R R
Baseline PPD testinig of dental workers 0 R R
Periodic PPD testing of dental workers N/A N/A* Y
Protocol of identifying and referring dental R R R
workers who may have active TB arnd/or
positive PPD test results
Protocol for investigating unprotected R R R
occupational exposures to TB
Rtrcmedd ed~;NA ntapial~ 1.totio a
Mnim and d setns sldi
: Low-, intermediate- or high-ris dental facilities g dental topatients who have, or are strg s
tious TB should provide TB isolation (Section LEI.
** Some very-low-risk dental settings providing treatment to patients at high risk for active TB may elect to use engineering controls for
general-use areas (for example, waiting rooms). These controls may include general ventilation, high-efficiency particulate air filtration or
ultraviolet germicidal irradiation [Section ILFI.
Very low risk. In a very-low-
risk dental setting, TB cases
have been reported in the com-
munity, but no patients with
active TB have been treated in
the facility during the preceding
12 months. Because DWs do not
provide initial medical assess-
ment of patients who may have
TB, but only conduct a limited
screening of patients for symp-
toms of active TB before provid-
ing dental treatment, the very-
low-risk category is appropriate
for many dental settings. Based
596 JADA, Vol. 126, May 1995
-SPECIAL BEPORTB
on this initial screening, pa-
tients suspected of having ac-
tive TB should be referred
promptly to a collaborating
facility for medical evaluation
and, when indicated, urgent
dental treatment.
Low risk and intermediate
risk. Some dental settings may
be classified in the low-risk or
intermediate-risk categories.
The low-risk facility provides
treatment to fewer than six
patients with active TB a year.
In addition, the low-risk facility
has no evidence of transmission
ofM. tuberculosis among DWs
or patients.
Dental facilities that provide
dental treatment to more than
six patients with active TB each
year, but have no evidence ofM.
tuberculosis transmission in the
facility, are categorized as being
at intermediate risk. A dental
facility at low or intermediate
risk might be one that accepts
patients with known or suspect-
ed active TB for urgent dental
care that must be performed
before the diagnosis ofTB is
ruled out or the patient has re-
ceived adequate treatment for
the disease.
High risk. High-risk dental
facilities are those in which the
PPD conversion rate exceeds
the previous rate in the same
facility or group, or in which a
cluster ofPPD conversions has
occurred, suggesting transmis-
sion ofM. tuberculosis among
DWs or patients. Many dental
facilities have only a small
number ofDWs, which makes it
difficult to interpret skin test
conversions. Thus, to determine
the significance of conversions,
a practitioner should obtain
appropriate consultation from
the public health department or
other sources of expertise.
From risk assessment to
written program. Based on
the risk assessment, a written
TB infection control program
should be developed for each den-
tal facility (Table 3). Elements of
an infection control program for
dental settings at minimal, very
low and low risk may differ from
those outlined in the CDC guide-
lines [Table 2]. For minimal-,
very-low- and low-risk dental
settings, a follow-up risk assess-
ment should occur at least an-
nually. Based on the results of
the follow-up assessment, a
problem evaluation [Section
II.K] may need to be conducted
or the facility's risk classifica-
Most dental settings
probably willfall into the
minimal- or very-low risk
categories.
tion changed. For example, the
very-low-risk category may be
appropriate for many dental
facilities. If, however, patients
with active TB have received
dental treatment in a facility
classified as being at very low
risk, the facility should be
assigned to the appropriate low,
intermediate- or high-risk cate-
gory. Categorical assignment
will depend on the number of
patients with TB treated in the
facility during the preceding 12
months and whether there is
evidence of nosocomial transmis-
sion ofM. tuberculosis in the
dental facility.
Elements ofTB infection con-
trol for intermediate- and high-
risk facilities are discussed in
detail in the guidelines [Section
II.BI. In general, intermediate-
risk and high-risk facilities
should perform the same ele-
ments of an infection-control
program for a low-risk facility




WHO MAY HAVE ACTIVE
TB [SECTION II.C3
Although dental personnel are
not responsible for diagnosing
and treating TB, they should be
trained to recognize and refer
patients with signs and symp-
toms that suggest TB, such as a
productive and persistent
cough, bloody sputum, night
sweats, weight loss, fever or
anorexia. The index of suspicion
for infectious TB among dental
patients will vary and depend
on the prevalence ofTB in and
other characteristics of the pop-
ulation that the facility serves
[Section I.B].
Medical histories should be
updated at each dental appoint-
ment and should include ques-
tions about symptoms ofTB and
about current treatment for
active TB. Any patient whose
medical history or symptoms
are suggestive of active TB
should be placed in an area sep-
arate from other patients or
dental personnel, asked to wear
a surgical mask to reduce ex-
pulsion of respiratory secretions
into the air, provided tissues for
coughing or sneezing and re-
ferred promptly for medical
evaluation and, when indicated,
urgent dental treatment.
MANAGING PATIENTS
WITH ACTIVE TB RELA-
TIVE TO PROVIDING DEN-
TAL CARE [SECTION lID]
Elective dental treatment
should be deferred for patients
known or suspected of having
active TB until they are receiv-
ing effective treatment and are
no longer infectious [Suppl. 1].
Low-, intermediate- or high-risk
facilities that provide urgent
dental treatment to patients
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with active TB should be
equipped with an appropriate
isolation room [Section II.EI.
Respiratory protection is recom-
mended for dental personnel
providing such treatment, and
this protection should meet cur-
rent CDC guideline recommen-
dations [Section II.G].
Each dental office in the mini-
mal- or very-low-risk category
should identify collaborating
facilities that are capable of eval-
uating, managing and/or provid-
ing urgent dental treatment to
patients with suspected or active
TB. These facilities should be
identified before DWs or patients
are placed at risk of possible
exposure to M. tuberculosis so
that patients suspected ofhaving
TB may be referred promptly.
The dental office and collaborat-
ing facility should establish a
referral agreement to prevent
inappropriate management and
inadequate follow-up of patients





patient populations at high risk
for active TB may elect to use
engineering controls in general-
use areas (waiting rooms, for
example). Such engineering
controls may include general
ventilation for dilution and
removal of potentially contami-
nated air, high-efficiency partic-
ulate air filtration (HEPA) or
UVGI. Protocols for mainte-




DWs who perform procedures
on patients who have, or are
strongly suspected of having,
infectious TB should use per-
sonal respiratory protection.
Therefore, low-, intermediate-
and high-risk dental settings
need to have a respiratory pro-
tection program for TB.
The CDC guidelines do not
recommend a specific respirator
but have outlined standard per-
formance criteria for respirators
used in health care settings for
protection against M. tuberculo-
sis. The Occupational Safety
and Health Administration res-
Elective dental treatment
should be deferredfor
patients known or suspect-
ed ofhaving active TB
until they are receiving
effective treatment and
are no longer infectious.
pirator protection standard
requires that all respiratory
protective devices used in the
workplace be certified by the
National Institute for Occupa-
tional Safety and Health, a
component of the CDC. NIOSH-
approved HEPA filter respira-
tors are the only currently
available air-purifying respira-
tors that meet or exceed the
standard performance criteria
recommended by the CDC. The
NIOSH respiratory certification
procedures are being revised to
take advantage of new technolo-
gy that will enable respirators
to meet the standard perfor-
mance criteria for TB respira-




[SECTION II.1 AND ILJ3
All DWs should receive periodic
employer-sponsored TB educa-
tion and training appropriate
for the dental facility's risk cat-
egory and for their individual
job category. The program
should include
- the basic concepts of patho-
genesis and transmission ofM.
tuberculosis;
- the difference between latent
TB infection and active disease;
- the signs and symptoms of
TB;
- the management and referral
of patients suspected of having
infectious TB;
- the principles ofTB infection
control;
- additional control measures
appropriate for facilities at
higher risk.
All DWs should receive coun-
seling about TB infection and
about the increased risk for
some immunocompromised per-
sons of developing active TB
once infected. The need for
additional training should be
evaluated periodically by the
person responsible for TB infec-
tion control in the office.
SCREENING HCWS FOR
LATENT OR ACTIVE TB
INFECTION [SECTION ILJ3
The risk assessment should be
used to determine the need for a
DW skin-testing program and
the appropriate frequency of
such testing. Baseline PPD skin
testing of all DWs, performed
by trained personnel, is recom-
mended at the beginning of em-
ployment for facilities in all risk
categories except minimal risk.
However, baseline PPD skin
testing ofDWs in the minimal-
risk category may be advisable
so that if an unprotected expo-
sure occurs, skin test conver-
sions can be distinguished from
positive PPD test results caused
by previous exposures. DWs
whose PPD test results are neg-
ative and who work in low-,
598 JADA, Vol. 126, May 1995
-SPECIAL REPORT
intermediate- and high-risk
facilities should undergo repeat-
ed PPD testing at regular inter-
vals as determined by the risk
assessment. In addition, DWs
should be tested whenever they
have been exposed to a patient
with TB without using appropriate
precautions [Section II.K31.
AnyDW with a recent positive
PPD test result should be evalu-
ated promptly by a physician for
TB infection or disease. DWs
with symptoms consistent with
active TB also should be evaluat-
ed promptly. Furthermore, they
should not return to the work-
place until their physicians have
ruled out a diagnosis ofTB or
until they are receiving adequate




This section provides general
guidance for conducting epidemi-
ologic investigations due to
= the occurrence ofPPD test




- situations in which a patient
who has undiagnosed active TB
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able to perform contact investi-
gations and PPD skin tests on
exposed people and to assist
DWs in identifying infection
control interventions that could
have prevented the exposure.
SUMMARY
The CDC guidelines offer recom-
mendations that will reduce the
risk oftransmission ofM. tuber-
culosis in health care settings and
provide HCWs with educational
material about TB. Although cer-
tain basic measures apply to all
dental settings, these guidelines
allow greater flexibility for imple-
menting additional TB infection
control measures on the basis of
risk.
For dental settings, effective
implementation of these recom-
mendations will require the
coordinated efforts of public
health departments; local, state
and national dental organiza-
tions; state dental directors;
federal agencies; academic
institutions; and individual
dental practitioners. In addi-
tion, the process of implement-
ing these recommendations
must safeguard, in accordance
with applicable state and feder-
al laws, the confidentiality and
civil rights of persons who have
active TB. .
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